СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ НЕСПЕЦИФИЧЕСКОГО ЯЗВЕННОГО КОЛИТА У ДЕТЕЙ
DOI:
https://doi.org/10.5281/zenodo.18497909Ключевые слова:
дети, неспецифический язвенный колит, витамин D, кишечная микрофлора.Аннотация
В данной статье рассматриваются актуальные проблемы неспецифического язвенного колита у
детей. На основе данных современных литературных источников анализируются современные представления
об этиопатогенезе и клинических особенностях течения неспецифического язвенного колита в детском возрасте.
Особое внимание уделено влиянию витамина D и состоянию кишечной микрофлоры в развитии данной патологии
у детей.
Библиографические ссылки
Rosen M. J., Dhawan A., Saeed S. A. Inflammatory bowel disease in children and adolescents // JAMA Pediatrics. –
– Vol. 169. – No. 11. – P. 1053–1060.
Aloi M., D’Arcangelo G., Pofi F., Vassallo F., Rizzo V., Nuti F., … Cucchiara S. Presenting features and disease course
of pediatric ulcerative colitis // Journal of Crohn’s and Colitis. – 2013. – Vol. 7. – No. 11. – P. e509–e515.
Imamovna K. K. Modern theories in the etiology of ulcerative colitis: a literature review // Modern American Journal of
Medical and Health Sciences. – 2025. – Vol. 1. – No. 2. – P. 39–49.
Diefenbach K. A., Breuer C. K. Pediatric inflammatory bowel disease // World Journal of Gastroenterology. – 2006. –
Vol. 12. – No. 20. – P. 3204.
Ivashkin V. T. et al. Diagnostics and treatment of peptic ulcer: clinical guidelines of the Russian Gastroenterological
Association // Russian Journal of Gastroenterology, Hepatology, Coloproctology. – 2016. – Vol. 26. – No. 6. – P. 40–54.
Regan B. P., Bousvaros A. Pediatric ulcerative colitis: a practical guide to management // Pediatric Drugs. – 2014. –
Vol. 16. – No. 3. – P. 189–198.
Turner D. et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus
guidelines // Journal of Pediatric Gastroenterology and Nutrition. – 2012. – Vol. 55. – No. 3. – P. 340–361.
Bousvaros A. et al. Differentiating ulcerative colitis from Crohn disease in children and young adults // Journal of
Pediatric Gastroenterology and Nutrition. – 2007. – Vol. 44. – No. 5. – P. 653–674.
Holick M. F. Vitamin D deficiency // New England Journal of Medicine. – 2007. – Vol. 357. – No. 3. – P. 266–281.
Bikle D. D. Vitamin D regulation of immune function // Vitamins & Hormones. – 2011. – Vol. 86. – P. 1–21.
Абдикаримов А. М. и др. // Наука и здравоохранение. Учредители: Медицинский университет Семей. – 2024. –
Т. 26. – № 5. – С. 213–220.
Mosli M. H., Parker C. E., Nelson S. A., Baker K. A., MacDonald J. K., Zou G. Y., Feagan B. G., Khanna R., Levesque
B. G., Jairath V. Histologic scoring indices for evaluation of disease activity in ulcerative colitis // Cochrane Database
of Systematic Reviews. – 2017. – Issue 5. – Art. No.: CD011256.
Nielsen O. H. et al. Managing vitamin D deficiency in inflammatory bowel disease // Frontline Gastroenterology. –
– Vol. 10. – No. 4. – P. 394–400.
Levin A. D. et al. Vitamin D deficiency in children with inflammatory bowel disease // Digestive Diseases and Sciences.
– 2011. – Vol. 56. – No. 3. – P. 830–836.
Levin A. D. et al. Vitamin D deficiency in children with inflammatory bowel disease // Digestive Diseases and Sciences.
– 2011. – Vol. 56. – No. 3. – P. 830–836.
Ananthakrishnan A. N. et al. Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease //
Gastroenterology. – 2012. – Vol. 142. – No. 3. – P. 482–489.
Nielsen O. H. et al. Managing vitamin D deficiency in inflammatory bowel disease // Frontline Gastroenterology. –
– Vol. 10. – No. 4. – P. 394–400.
Szodoray P. et al. The complex role of vitamin D in autoimmune diseases // Scandinavian Journal of Immunology. –
– Vol. 68. – No. 3. – P. 261–269.
Mora J. R., Iwata M., Von Andrian U. H. Vitamin effects on the immune system: vitamins A and D take centre stage //
Nature Reviews Immunology. – 2008. – Vol. 8. – No. 9. – P. 685–698.
Frank D. N. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory
bowel diseases // Proceedings of the National Academy of Sciences. – 2007. – Vol. 104. – No. 34. – P. 13780–13785.
Sokol H. et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota // Inflammatory Bowel Diseases. – 2009.
– Vol. 15. – No. 8. – P. 1183–1189.
Manichanh C. et al. The gut microbiota in IBD // Nature Reviews Gastroenterology & Hepatology. – 2012. – Vol. 9. –
No. 10. – P. 599–608.
Frank D. N. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory
bowel diseases // Proceedings of the National Academy of Sciences. – 2007. – Vol. 104. – No. 34. – P. 13780–13785.
Machiels K. et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii
defines dysbiosis in patients with ulcerative colitis // Gut. – 2014. – Vol. 63. – No. 8. – P. 1275–1283.
Kostic A. D., Xavier R. J., Gevers D. The microbiome in inflammatory bowel disease: current status and the future
ahead // Gastroenterology. – 2014. – Vol. 146. – No. 6. – P. 1489–1499.
Louis P., Flint H. J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large
intestine // FEMS Microbiology Letters. – 2009. – Vol. 294. – No. 1. – P. 1–8.
Bouhuys M., Lexmond W. S., van Rheenen P. F. Pediatric inflammatory bowel disease // Pediatrics. – 2023. – Vol.
– No. 1.
Kugathasan S. et al. Prediction of complicated disease course for children newly diagnosed with Crohn’s disease //
The Lancet. – 2017. – Vol. 389. – No. 10080. – P. 1710–1718.
Korn T. et al. IL-17 and Th17 cells // Annual Review of Immunology. – 2009. – Vol. 27. – No. 1. – P. 485–517.
Brown S. J., Mayer L. The immune response in inflammatory bowel disease // American Journal of Gastroenterology.
– 2007. – Vol. 102. – No. 9. – P. 2058–2069.
Sands B. E., Kaplan G. G. The role of TNF-α in ulcerative colitis // The Journal of Clinical Pharmacology. – 2007. – Vol.
– No. 8. – P. 930–941.
Molodecky N. A., Soon I. S., Rabi D. M. et al. Global IBD incidence // Gastroenterology. – 2012. – Vol. 142. – P. 46–54.
Kaplan G. G. The global burden of IBD: from 2015–2025 // Nature Reviews Gastroenterology & Hepatology. – 2015.
– Vol. 12. – No. 12. – P. 720–727.
Matsuoka K., Kanai T. Microbiota and IBD // Immunological Reviews. – 2017. – Vol. 279. – P. 23–38.
Peterson L. W., Artis D. Intestinal epithelial cells // Nature Reviews Immunology. – 2014. – Vol. 14. – P. 141–153.
Salzman N. H., Underwood M. A., Bevins C. L. Paneth cells // Annual Review of Immunology. – 2007. – Vol. 25. – P.
–347.
Turner J. R. Intestinal barrier function // Nature Reviews Immunology. – 2009. – Vol. 9. – P. 799–809.
Schwiertz A., Taras D., Schäfer K. et al. Microbiota in IBD // World Journal of Gastroenterology. – 2010. – Vol. 16. – P.
–1845.
Sartor R. B. Microbial influences in IBD // Gastroenterology. – 2008. – Vol. 134. – P. 577–594.
Turner D., Ruemmele F. M., Orlanski-Meyer E. et al. Management of pediatric UC // Journal of Pediatric Gastroenterology
and Nutrition. – 2018. – Vol. 67. – P. 292–310.
Benchimol E. I., Fortinsky K. J., Gozdyra P. et al. Epidemiology of pediatric IBD // American Journal of Gastroenterology.
– 2011. – Vol. 106. – P. 1591–1601.
Lewis J. D., Abreu M. T. Diet and IBD // Nature Reviews Gastroenterology & Hepatology. – 2017. – Vol. 14. – P. 1–14.
Загрузки
Опубликован
Выпуск
Раздел
Лицензия
Copyright (c) 2026 MUHANDISLIK VA IQTISODIYOT
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.